From generics to branded products, Chartwell is able to bring a level of quality and consistency to the market that's only possible through experience and dedication.
Sometimes looking forward requires you to first look back. While we continue to focus on the development of new products, we have methodically acquired an extensive portfolio of tried-and-true, sustainable ANDA and NDA products. Chartwell's goal is to evaluate existing products to determine how we can improve upon them through updates in API and excipients, manufacturing processes or batch sizes. It's a proven practice that maintains quality, improves reliability, and adds to overall time savings and cost-efficient production, ultimately benefiting our customers and their patients.